Showing 1911-1920 of 3022 results for "".
Insights on PsA Management
https://practicaldermatology.com/programs/practical-dermatology/insights-on-psa-management/23665/With about one-third of psoriasis patients likely to develop joint disease, dermatologists must be prepared to comanage PsA symptoms.Get The Word Out: Branding Plus Online Presence Equals Reputation Building
https://practicaldermatology.com/topics/practice-management/get-the-word-out-branding-plus-online-presence-equals-reputation-building/23441/Your online branding program and associated initiatives can improve your web ranking and your appeal to patients.Update on Approaches to Hair Restoration
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-approaches-to-hair-restoration/23317/From investigational JAK inhibitors to eyebrow transplants, here’s a look at the latest in hair restoration.End Game: Why You Need Long-term Goals and an Exit Plan
https://practicaldermatology.com/topics/practice-management/end-game-why-you-need-long-term-goals-and-an-exit-plan/23217/Establishing long-term goals helps you make smart hiring and firing decisions along the way.Technology to Improve Your Patient Consult and Experience
https://practicaldermatology.com/topics/practice-management/technology-to-improve-your-patient-consult-and-experience/23171/Look for ways to optimize technology for the good of your practice.Letter to the Editor: Dermatologists Must Focus on Safety; Understand Device Clearances
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/letter-to-the-editor/23072/Exploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?Interoperability Redux
https://practicaldermatology.com/topics/practice-management/interoperability-redux/20455/Is the new push for interoperability déjà vu all over again?High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.